Oxidative Medicine and Cellular Longevity / 2016 / Article / Tab 1 / Research Article
Periodic Exposure of Keratinocytes to Cold Physical Plasma: An In Vitro Model for Redox-Related Diseases of the Skin Table 1 Expression (fold change compared to untreated control) of tight and adherent junction proteins with at least one significant modulation throughout the time course of plasma treatment. Actin expression remained relatively unchanged.
Gene name Gene ID w2 w6 w8 w10 w12 Occludin OCLN 1.32 −1.15 −2.11 −2.02 −1.86 Claudin 1 CLDN1 −1.11 −2.32 −1.38 −1.01 1.04 Claudin 2 CLDN2 2.17 2.11 1.40 1.48 −1.26 Claudin 3 CLDN3 1.97 1.68 −4.12 −2.41 −1.27 Claudin 4 CLDN4 1.66 3.19 −1.02 1.00 1.08 Claudin 6 CLDN6 1.59 2.52 −1.16 1.37 −1.99 Claudin 7 CLDN7 1.07 −1.38 −2.03 −1.56 −1.08 Claudin 8 CLDN8 1.05 −10.46 −1.86 −1.31 1.06 Claudin 12 CLDN12 1.42 2.21 1.67 1.78 1.28 Claudin 17 CLDN17 1.86 −1.70 −1.93 −2.66 −2.61 Claudin 18 CLDN18 4.86 −1.11 −1.27 −1.74 −1.81 Claudin 19 CLDN19 1.86 −2.46 −2.41 −1.04 1.38 Claudin 22 CLDN22 17.47 2.93 −1.66 1.26 −1.52 Claudin 23 CLDN23 −1.24 −1.68 −3.49 −2.51 −1.69 Zonula occludens protein 1 TJP1 (ZO-1) 1.68 3.06 1.14 −1.09 1.10 Zonula occludens protein 2 TJP2 (ZO-2) −1.05 −2.27 −2.26 −1.53 −1.07 Zonula occludens protein 3 TJP3 (ZO-3) −1.62 −2.60 −1.45 −1.08 −1.39 Cadherin 2 CDH2 4.78 46.49 11.74 1.56 6.26 Cadherin 3 CDH3 1.37 2.10 1.70 1.26 1.25 Cadherin 4 CDH4 1.66 3.19 −1.02 1.00 1.08 Cadherin 5 CDH5 1.36 2.06 −1.06 1.78 1.15 Cadherin 7 CDH7 1.85 1.97 1.32 2.29 2.27 Cadherin 9 CDH9 2.53 −3.54 −3.35 −2.47 −2.51 Cadherin 10 CDH10 2.14 1.32 1.31 1.63 1.20 Cadherin 13 CDH13 −1.19 2.95 3.40 3.34 −1.09 Cadherin 16 CDH16 3.55 −1.47 −1.42 −1.82 1.11 Cadherin 18 CDH18 2.04 −1.14 2.48 1.18 −1.02 Cadherin 19 CDH19 2.32 −1.35 −1.34 −1.35 −1.31 Cadherin 20 CDH20 5.80 1.76 2.35 1.67 −1.14 Cadherin 23 CDH23 3.07 1.02 2.48 1.47 1.90 Cadherin 24 CDH24 1.53 2.83 1.61 1.25 1.06 α -actin 2ACTA2 1.10 −1.21 2.70 1.41 1.06 β -actinACTB 1.34 1.35 1.23 1.04 1.02 β -catenin 1CTNNB1 1.62 2.05 1.27 1.03 1.21